Anatomical analysis of the motor endplate zones of the suprascapular nerve to the infraspinatus muscle and its clinical significance in managing pain disorder
- 29 March 2023
- journal article
- research article
- Published by Wiley in Journal of Anatomy
- Vol. 243 (3) , 467-474
Abstract
Myofascial pain syndrome caused by myofascial trigger points is a musculoskeletal disorder commonly encountered in clinical practice. The infraspinatus muscle is the region most frequently involved in the myofascial pain syndrome in the scapular region. The characteristics of the myofascial trigger points are that they can be found constantly in the motor endplate zone. However, localizing myofascial trigger points within the motor endplate zone and establishing an accurate injection site of the infraspinatus muscle has been challenging because the anatomical position of the motor endplate zone of the infraspinatus muscle is yet to be described. Therefore, this cadaveric study aimed to scrutinize the motor endplate zone of the infraspinatus muscle, propose potential myofascial trigger points within the muscle, and recommend therapeutic injection sites. Twenty specimens of the infraspinatus muscle for nerve staining and 10 fresh frozen cadavers for evaluation of the injection were used in this study. The number of nerve branches penetrating the infraspinatus muscle and their entry locations were analyzed and photographed. Modified Sihler's staining was performed to examine the motor endplate regions of the infraspinatus muscle. The nerve entry points were mostly observed in the center of the muscle belly. The motor endplate was distributed equally throughout the infraspinatus muscle, but the motor endplate zone was primarily identified in the B area, which is approximately 20-40% proximal to the infraspinatus muscle. The second-most common occurrence of the motor endplate zone was observed in the center of the muscle. These detailed anatomical data would be very helpful in predicting potential pain sites and establishing safe and effective injection treatment using botulinum neurotoxin, steroids, or lidocaine to alleviate the pain disorder of the infraspinatus muscle.Keywords
Funding Information
- National Research Foundation of Korea (2022R1I1A1A01069499, NRF‐2019R1C1C1010776)
This publication has 26 references indexed in Scilit:
- Botulinum toxin type A injections in the psoas muscle of children with cerebral palsy: Muscle atrophy after motor end plate-targeted injectionsResearch in Developmental Disabilities, 2013
- High prevalence of shoulder girdle muscles with myofascial trigger points in patients with shoulder painBMC Musculoskeletal Disorders, 2011
- Botulinum Toxin A in the Treatment of Chronic Tension‐Type Headache With Cervical Myofascial Trigger Points: A Randomized, Double‐Blind, Placebo‐Controlled Pilot StudyHeadache: The Journal of Head and Face Pain, 2009
- Botulinum Toxin Dilution and Endplate Targeting in Spasticity: A Double-Blind Controlled StudyArchives of Physical Medicine and Rehabilitation, 2009
- Topographical mapping and mechanical pain sensitivity of myofascial trigger points in the infraspinatus muscleEuropean journal of pain, 2008
- Intramuscular Botulinum Toxin-A Reduces Hemiplegic Shoulder PainStroke, 2008
- Botulinum toxin A for myofascial trigger point injection: A qualitative systematic reviewEuropean journal of pain, 2007
- Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport®) for the relief of upper back myofascial pain syndrome: Results from a randomized double-blind placebo-controlled multicentre studyPain, 2006
- A double-blind, controlled study of botulinum toxin A in chronic myofascial painNeurology, 2006
- Botulinum toxin in the treatment of myofascial pain syndromePain, 1994